Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thea J A M van der Velden

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pediatric Nephrology (Berlin, Germany)|June 19, 2007
Interactions of Shiga-like toxin with human peripheral blood monocytesJoyce M Geelen, Thea J A M van der Velden, Lambertus P W J van den Heuvel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2006
Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytesJoyce M Geelen, Thea J A M van der Velden, D Maroeska W M Te Loo, et al.
Microorganisms|October 23, 2021
The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin <i>E. coli</i> Mediated HUSWouter J C Feitz, Romy Bouwmeester, Thea J A M van der Velden, et al.
Toxins|July 9, 2020
Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular EndotheliumElena B Volokhina, Wouter J C Feitz, Lonneke M Elders, et al.
International Journal of Molecular Sciences|June 2, 2021
Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult OriginWouter J C Feitz, Petra A van Setten, Thea J A M van der Velden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2021
The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative PathwayMarloes A H M Michels, Rianne J F Maas, Thea J A M van der Velden, et al.
Clinical Immunology (Orlando, Fla.)|June 27, 2015
Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndromeElena B Volokhina, Nicole C A J van de Kar, Grethe Bergseth, et al.
Toxins|August 6, 2020
Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial CellsWouter J C Feitz, Nicole C A J van de Kar, Ian Cheong, et al.
Frontiers in Immunology|November 13, 2023
Modeling complement activation on human glomerular microvascular endothelial cellsKes H Stevens, Laura M Baas, Thea J A M van der Velden, et al.
Kidney International Reports|December 12, 2022
Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: <i>In</i> <i>V</i> <i>itro</i> DetectionSusan T Veissi, Bart Smeets, Joanna A E van Wijk, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pediatric Nephrology (Berlin, Germany)|June 19, 2007
Interactions of Shiga-like toxin with human peripheral blood monocytesJoyce M Geelen, Thea J A M van der Velden, Lambertus P W J van den Heuvel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2006
Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytesJoyce M Geelen, Thea J A M van der Velden, D Maroeska W M Te Loo, et al.
Microorganisms|October 23, 2021
The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin <i>E. coli</i> Mediated HUSWouter J C Feitz, Romy Bouwmeester, Thea J A M van der Velden, et al.
Toxins|July 9, 2020
Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular EndotheliumElena B Volokhina, Wouter J C Feitz, Lonneke M Elders, et al.
International Journal of Molecular Sciences|June 2, 2021
Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult OriginWouter J C Feitz, Petra A van Setten, Thea J A M van der Velden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2021
The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative PathwayMarloes A H M Michels, Rianne J F Maas, Thea J A M van der Velden, et al.
Clinical Immunology (Orlando, Fla.)|June 27, 2015
Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndromeElena B Volokhina, Nicole C A J van de Kar, Grethe Bergseth, et al.
Toxins|August 6, 2020
Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial CellsWouter J C Feitz, Nicole C A J van de Kar, Ian Cheong, et al.
Frontiers in Immunology|November 13, 2023
Modeling complement activation on human glomerular microvascular endothelial cellsKes H Stevens, Laura M Baas, Thea J A M van der Velden, et al.
Kidney International Reports|December 12, 2022
Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: <i>In</i> <i>V</i> <i>itro</i> DetectionSusan T Veissi, Bart Smeets, Joanna A E van Wijk, et al.
Pageof 2